• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Eur Acad Dermatol Venereol . Autoantibodies in Covid19 - A model for viral induced autoimmunity

tetano

Editor, Senior Moderator
J Eur Acad Dermatol Venereol


. 2021 May 25.
doi: 10.1111/jdv.17396. Online ahead of print.
Autoantibodies in Covid19 - A model for viral induced autoimmunity


J Berger[SUP] 1 [/SUP], S Volc[SUP] 1 [/SUP]



Affiliations

Abstract

the novel Coronavirus SARS-CoV-2 is suspected of acting as a trigger for autoimmune diseases and the production of autoantibodies. Retinoic acid-inducible gene (RIG)-I-like receptors (RLR), including melanoma differentiation-associated protein 5 (MDA5) and RIG-I, recognize the double-strand (ds) virus RNA and induce the production of Type I interferon (Type I IFN) as well as pro-inflammatory cytokines like Interleukin (IL)-6.

Keywords: MDA5; SARS-CoV2; autoimmunity; dermatomyositis; lupus anticoagulant; type I interferon.
 
Back
Top Bottom